Skip to content

Clinical trials

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Country / region: Japan Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20161
20171
20191
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting2
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb1
Celgene1
Daiichi Sankyo1
Daiichi Sankyo Co., Ltd.1
GlaxoSmithKline1
HUYABIO International, LLC.1
Otsuka Medical Devices Co., Ltd. Japan1
SymBio Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma8
Lymphoma4
Immunoblastic Lymphadenopathy2
Leukemia-Lymphoma, Adult T-Cell2
Lymphoma, Large-Cell, Anaplastic2
Lymphoma, T-Cell2
Lymphoma, T-Cell, Peripheral2
Recurrence2
Arrhythmias, Cardiac1
Cataract1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.